BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

768 related articles for article (PubMed ID: 11331952)

  • 1. Expression of the retinoblastoma-related gene Rb2/p130 is downregulated in atypical endometrial hyperplasia and adenocarcinoma.
    Susini T; Massi D; Paglierani M; Masciullo V; Scambia G; Giordano A; Amunni G; Massi G; Taddei GL
    Hum Pathol; 2001 Apr; 32(4):360-7. PubMed ID: 11331952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. bcl-2 is down-regulated in atypical endometrial hyperplasia and adenocarcinoma.
    Henderson GS; Brown KA; Perkins SL; Abbott TM; Clayton F
    Mod Pathol; 1996 Apr; 9(4):430-8. PubMed ID: 8729985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of Rb2/p130 in breast and endometrial cancer: correlations with hormone receptor status.
    Milde-Langosch K; Goemann C; Methner C; Rieck G; Bamberger AM; Löning T
    Br J Cancer; 2001 Aug; 85(4):546-51. PubMed ID: 11506494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced transcription of the RB2/p130 gene in human lung cancer.
    Xue Jun H; Gemma A; Hosoya Y; Matsuda K; Nara M; Hosomi Y; Okano T; Kurimoto F; Seike M; Takenaka K; Yoshimura A; Toyota M; Kudoh S
    Mol Carcinog; 2003 Nov; 38(3):124-9. PubMed ID: 14587097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gain of OGP, an estrogen-regulated oviduct-specific glycoprotein, is associated with the development of endometrial hyperplasia and endometrial cancer.
    Woo MM; Alkushi A; Verhage HG; Magliocco AM; Leung PC; Gilks CB; Auersperg N
    Clin Cancer Res; 2004 Dec; 10(23):7958-64. PubMed ID: 15585630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclical change of hMSH2 protein expression in normal endometrium during the menstrual cycle and its overexpression in endometrial hyperplasia and sporadic endometrial carcinoma.
    Hamid AA; Mandai M; Konishi I; Nanbu K; Tsuruta Y; Kusakari T; Kariya M; Kita M; Fujii S
    Cancer; 2002 Feb; 94(4):997-1005. PubMed ID: 11920468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of hyaluronic acid and its receptors, CD44s and CD44v6, in normal, hyperplastic, and neoplastic endometrium.
    Afify AM; Craig S; Paulino AF; Stern R
    Ann Diagn Pathol; 2005 Dec; 9(6):312-8. PubMed ID: 16308159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular analysis of endometrial hyperplasia in HNPCC-suspicious patients may predict progression to endometrial carcinoma.
    Sutter C; Dallenbach-Hellweg G; Schmidt D; Baehring J; Bielau S; von Knebel Doeberitz M; Gebert J
    Int J Gynecol Pathol; 2004 Jan; 23(1):18-25. PubMed ID: 14668545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptosis and apoptosis-related factors Bcl-2, Bax, tumor necrosis factor-alpha, and NF-kappaB in human endometrial hyperplasia and carcinoma.
    Vaskivuo TE; Stenbäck F; Tapanainen JS
    Cancer; 2002 Oct; 95(7):1463-71. PubMed ID: 12237915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent loss of expression of the cyclin-dependent kinase inhibitor p27(Kip1) in estrogen-related Endometrial adenocarcinomas.
    Masciullo V; Susini T; Zamparelli A; Bovicelli A; Minimo C; Massi D; Taddei G; Maggiano N; De Iaco P; Ceccaroni M; Bovicelli L; Amunni G; Mancuso S; Scambia G; Giordano A
    Clin Cancer Res; 2003 Nov; 9(14):5332-8. PubMed ID: 14614018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in the retinoblastoma-related gene RB2/p130 in lung tumors and suppression of tumor growth in vivo by retrovirus-mediated gene transfer.
    Claudio PP; Howard CM; Pacilio C; Cinti C; Romano G; Minimo C; Maraldi NM; Minna JD; Gelbert L; Leoncini L; Tosi GM; Hicheli P; Caputi M; Giordano GG; Giordano A
    Cancer Res; 2000 Jan; 60(2):372-82. PubMed ID: 10667590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical study of apoptosis-related Bcl-2 protein and its correlation with proliferation indices (Ki67, PCNA), tumor suppressor genes (p53, pRb), the oncogene c-erbB-2, sex steroid hormone receptors and other clinicopathological features, in normal, hyperplastic and neoplastic endometrium.
    Mitselou A; Ioachim E; Kitsou E; Vougiouklakis T; Zagorianakou N; Makrydimas G; Stefanaki S; Agnantis NJ
    In Vivo; 2003; 17(5):469-77. PubMed ID: 14598611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Digital morphometry of cytologic aspirate endometrial samples.
    Mahovlić V; Ovanin-Rakić A; Skopljanac-Macina L; Barisić A; Rajhvajn S; Juric D; Projić IS; Ilić-Forko J; Babić D; Skrablin-Kucić S; Bozikov J
    Coll Antropol; 2010 Mar; 34(1):45-51. PubMed ID: 20437635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KAI1 metastasis suppressor protein is down-regulated during the progression of human endometrial cancer.
    Liu FS; Dong JT; Chen JT; Hsieh YT; Ho ES; Hung MJ; Lu CH; Chiou LC
    Clin Cancer Res; 2003 Apr; 9(4):1393-8. PubMed ID: 12684410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of Rb2/p130 and p107 in normal human tissues and in primary lung cancer.
    Baldi A; Esposito V; De Luca A; Fu Y; Meoli I; Giordano GG; Caputi M; Baldi F; Giordano A
    Clin Cancer Res; 1997 Oct; 3(10):1691-7. PubMed ID: 9815552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coabnormal expression of cyclin D1 and p53 protein in human uterine endometrial carcinomas.
    Nikaido T; Li SF; Shiozawa T; Fujii S
    Cancer; 1996 Sep; 78(6):1248-53. PubMed ID: 8826947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of nm23 in normal, hyperplastic and neoplastic endometrial tissues.
    Brustmann H; Naudé S
    Pathol Res Pract; 1999; 195(12):829-34. PubMed ID: 10631718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression pattern of PAX2 in hyperplastic and malignant endometrium.
    Kahraman K; Kiremitci S; Taskin S; Kankaya D; Sertcelik A; Ortac F
    Arch Gynecol Obstet; 2012 Jul; 286(1):173-8. PubMed ID: 22274645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RB2/p130 gene-enhanced expression down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in vivo.
    Claudio PP; Stiegler P; Howard CM; Bellan C; Minimo C; Tosi GM; Rak J; Kovatich A; De Fazio P; Micheli P; Caputi M; Leoncini L; Kerbel R; Giordano GG; Giordano A
    Cancer Res; 2001 Jan; 61(2):462-8. PubMed ID: 11212232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of HER-2/neu oncogene in normal, hyperplastic, and malignant endometrium.
    Rasty G; Murray R; Lu L; Kubilis P; Benrubi G; Masood S
    Ann Clin Lab Sci; 1998; 28(3):138-43. PubMed ID: 9646853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.